Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
startups
3
×
biogen
boston
clinical trials
investing
san francisco blog main
san francisco top stories
89bio
abbvie
adrian krainer
alexion pharmaceuticals
alzheimer europe conference
alzheimer's disease
antisense oligonucleotide
astrazeneca
azacitidine
bain capital
benzodiazepines
beta-thalassemia
biotech ipos
blackstone group
blackstone life sciences
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cerevel therapeutics
columbia university
convergence pharmaceuticals
crispr therapeutics
cystic fibrosis
What
research
3
×
aims
biotech
drugs
medicines
new
alzheimer’s
annual
approach
assessed
attention
backed
based
bio
called
cause
ceo
communities
conference
debuts
developing
drug
epigenetic
epigenetics
epilepsy
esmo
europe
field
flagship’s
genes
genetic
germany
hosted
investment
links
marcio
morning
munich
mutations
neuro
Language
unset
Current search:
research
×
startups
×
" boston blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More